Company intelligence / Profile preview

Dymaxium

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Dymaxium is a software and services company in the pharmaceutical sector focused on market access, payer engagement, and HEOR tools, acquired by Xcenda. It develops platforms like integrations for the AMCP eDossier system and has expertise in web development for healthcare applications. No clinical pipeline, therapeutic modalities, or R&D programs are associated with it, as it operates in services rather than drug development. Estimated revenue is $7 million, with operations based in Toronto, Ontario.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Advera Health Analytics

Beyond the preview

Go deeper on Dymaxium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dymaxium.

Explore the full profile